I am aware that product development is done, however to the best of my knowledge toxicology for the latest iteration hasn't been reported. Happy to be corrected, kindly send me a link to where your info is coming from if possible. I'd be very pleased to hear that toxicology is completed for the 2nd generation/prolonged infusion, as that step would be necessary to progress to deal negotiation.
I am aware that product development is done, however to the best...
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $1.587K | 328.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 52136689 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 60263860 | 24 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
0.4¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.4¢ | 0.5¢ | 0.4¢ | 1091555 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| AVE (ASX) Chart |